Complex Injectable Market, By Molecule Type (Small Molecule and Biologics-Based), By Therapeutic Application (Oncology, Autoimmune Diseases, Infectious Diseases, Metabolic Disorders , Hematological Disorders , Neurological Disorders , Ophthalmology , Dermatology , Cardiovascular Diseases , and Others (Rare Diseases)), By Product Type (Monoclonal Antibodies , Peptides and Proteins , Antibiotics , Chemotherapy Agents , Hormones , Blood Factors , Gene Therapy Products , Cell Therapy Products , and Others (Oligonucleotides)), By Packaging Type (Vials , Prefilled Syringes , Ampoules , Cartridges , and Others (IV Bags)), By Route of Administration (Intravenous (IV) , Intramuscular (IM) , Subcutaneous (SC) , Intrathecal , Intra-articular , and Other Parenteral Routes (Intradermal)), By Age Group (Pediatric, Adult, and Geriatric), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers (ASCs), and Home Healthcare Settings), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)